Compositions and methods for the diagnosis and treatment of tumor

Details for Australian Patent Application No. 2008202000 (hide)

Owner Genentech, Inc.

Inventors Polakis, Paul; Hillan, Kenneth J; Spencer, Susan D; Wu, Thomas D; Zhang, Zemin; Williams, P Mickey; Frantz, Gretchen; Phillips, Heidi S

Agent Griffith Hack

Pub. Number AU-A-2008202000

Parent 2002330015

Filing date 6 May 2008

Wipo publication date 29 May 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/7036 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

22 May 2008 Complete Application Filed

29 May 2008 Application Open to Public Inspection

  Published as AU-A-2008202000

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202001-Methods of administering antiTNFalpha antibodies

2008201999-End-to-end anastomosis instrument and method for performing same